New uterine sampler aims to make cancer detection less painful
NCT ID NCT04258449
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new device called DOvEEgene Fleur for collecting cells from inside the uterus to detect cancers of the endometrium, tubes, and ovaries. The goal is to see if it is less painful and easier to use than the current brush, while still collecting enough cells for accurate testing. Forty women with suspected or confirmed gynecological cancer will try the device before surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
DOvEEgene Fleur endometrial sampling device
What this could lead to
If successful, this could lead to a more comfortable and effective way to collect samples for early detection of uterine and ovarian cancers.
What could go wrong
This is a small, early-stage study with only 40 participants, so results may not apply to everyone. The device is new and its performance compared to standard tools is still being tested.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Royal Victoria Hospital (Glen Site)
RECRUITINGMontreal, Quebec, H4A 3J1, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••